Skip to content
Skip to footer
Home
Solution
Team
News
Contact
Close
Home
Solution
Team
News
Contact
News
Sartar was granted a Japan patent
January 25, 2019
Sartar was awarded a patent in Japan for the use of anagrelide in cancer therapy.
You May Also Like
News
Sartar was chosen among the top 30 innovative life science companies in RESI Innovation Challenge
News
Sartar was awarded a U.S. patent
News
Sartar Therapeutics was selected to NOME mentoring program